Treatment for Stage IV Prostate cancer
Dear OncoLink "Ask The Experts,"
I have been diagnosed with stage 4 prostate cancer. Is it better to start total androgen ablation right away or first just leuitinizing hormone?
David J Vaughn, MD, Medical Director of the Abramson Family Cancer Research Institute and Associate Professor of Medicine, Hematology-Oncology at the Abramson Cancer Center of the University of Pennsylvania, responds:
In general, most believe that total androgen blockade such as luteinizing hormone-releasing hormone (LHRH) agonist plus anti-androgren therapy or orchiectomy plus anti-androgen therapy is not significantly superior to LHRH agonist monotherapy or orchiectomy monotherapy. A recent meta-analysis suggests about a 2-3% improvement in survival for total androgen blockade. One needs to balance this against the cost and toxicity of the anti-androgen, which are not negligible. The only caveat is that prior to initiating LHRH agonist therapy a period of anti-androgen blockade prevents a flare in symptoms.
OncoLink is designed for educational purposes only and is not engaged in rendering medical advice or professional services. The information provided through OncoLink should not be used for diagnosing or treating a health problem or a disease. It is not a substitute for professional care. If you have or suspect you may have a health problem or have questions or concerns about the medication that you have been prescribed, you should consult your health care provider.
Information Provided By: www.oncolink.org | © 2016 Trustees of The University of Pennsylvania